As briefly mentioned above, in AD APP is preferentially processed into amyloidogenic Aβ1-42 in the endolysosomal pathway of neurons after internalization via CME (Koo and Squazzo, 1994; Wu and Yao, 2009). The gene discussed is APP; the disease is Alzheimer disease.